<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>17(6)</volume><submitter>Shao Q</submitter><pubmed_abstract>Liposomes have been widely investigated as a class of promising antibiotic delivery systems for the treatment of life-threatening bacterial infections. However, the inevitable formation of protein corona on the liposomal surface can heavily impact &lt;i>in vivo&lt;/i> performance. A better understanding of the effects of protein corona on liposomal behavior can significantly improve antibacterial liposomal drug development. Here, the critical role of protein corona in mediating liposome-bacteria interactions was elucidated. Adsorption of negatively charged protein on cationic liposome weakened electrostatic attraction-enhanced liposomal binding to the bacteria. Cumulative complement deposition on anionic liposome composed of phosphatidylglycerol (DSPG sLip) contributed to a superior binding affinity of DSPG sLip to planktonic bacteria and biofilms, which was exploited to enhance bacteria-targeted drug delivery. In both &lt;i>S. aureus&lt;/i>-related osteomyelitis and pneumonia mice models, DSPG sLip was demonstrated as a promising antibiotic nanocarrier for managing MRSA infection, indicating the benefits of lipid composition-based protein corona modulation in liposomal antibiotic delivery for bacterial infection treatment.</pubmed_abstract><journal>Asian journal of pharmaceutical sciences</journal><pagination>855-866</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9800951</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Protein corona mediated liposomal drug delivery for bacterial infection management.</pubmed_title><pmcid>PMC9800951</pmcid><pubmed_authors>Li G</pubmed_authors><pubmed_authors>Qian J</pubmed_authors><pubmed_authors>Zhan C</pubmed_authors><pubmed_authors>Ding T</pubmed_authors><pubmed_authors>Pan F</pubmed_authors><pubmed_authors>Shen S</pubmed_authors><pubmed_authors>Wei X</pubmed_authors><pubmed_authors>Shao Q</pubmed_authors></additional><is_claimable>false</is_claimable><name>Protein corona mediated liposomal drug delivery for bacterial infection management.</name><description>Liposomes have been widely investigated as a class of promising antibiotic delivery systems for the treatment of life-threatening bacterial infections. However, the inevitable formation of protein corona on the liposomal surface can heavily impact &lt;i>in vivo&lt;/i> performance. A better understanding of the effects of protein corona on liposomal behavior can significantly improve antibacterial liposomal drug development. Here, the critical role of protein corona in mediating liposome-bacteria interactions was elucidated. Adsorption of negatively charged protein on cationic liposome weakened electrostatic attraction-enhanced liposomal binding to the bacteria. Cumulative complement deposition on anionic liposome composed of phosphatidylglycerol (DSPG sLip) contributed to a superior binding affinity of DSPG sLip to planktonic bacteria and biofilms, which was exploited to enhance bacteria-targeted drug delivery. In both &lt;i>S. aureus&lt;/i>-related osteomyelitis and pneumonia mice models, DSPG sLip was demonstrated as a promising antibiotic nanocarrier for managing MRSA infection, indicating the benefits of lipid composition-based protein corona modulation in liposomal antibiotic delivery for bacterial infection treatment.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2025-04-04T21:04:44.527Z</modification><creation>2025-04-04T21:04:44.527Z</creation></dates><accession>S-EPMC9800951</accession><cross_references><pubmed>36600900</pubmed><doi>10.1016/j.ajps.2022.10.003</doi></cross_references></HashMap>